Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal Analysis of Urinary Cytokines and Biomarkers in COVID-19 Patients with Subclinical Acute Kidney Injury.
Casas-Aparicio G, Alvarado-de la Barrera C, Escamilla-Illescas D, León-Rodríguez I, Del Río-Estrada PM, González-Navarro M, Calderón-Dávila N, Olmedo-Ocampo R, Castillejos-López M, Figueroa-Hernández L, Peralta-Prado AB, Luna-Villalobos Y, Piten-Isidro E, Fernández-Campos P, Juárez-Díaz A, Piekarska K, Ávila-Ríos S. Casas-Aparicio G, et al. Int J Mol Sci. 2022 Dec 6;23(23):15419. doi: 10.3390/ijms232315419. Int J Mol Sci. 2022. PMID: 36499745 Free PMC article.
Double-Negative T Cell Number and Phenotype Alterations Before and After Effective Antiretroviral Treatment in Persons Living with HIV.
Briceño O, Peralta-Prado A, Garrido-Rodríguez D, Romero-Mora K, Chávez-Torres M, Pinto Cardoso S, Alvarado de la Barrera C, Reyes-Terán G, Ávila-Ríos S. Briceño O, et al. AIDS Res Hum Retroviruses. 2023 Mar;39(3):104-113. doi: 10.1089/AID.2022.0047. Epub 2023 Jan 9. AIDS Res Hum Retroviruses. 2023. PMID: 36511386
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes.
Serna-Muñoz R, Hernández-Terán A, Soto-Nava M, Tapia-Trejo D, Ávila-Ríos S, Mejía-Nepomuceno F, García E, Castillejos-López M, Higuera-Iglesias AL, Aquino-Gálvez A, Thirion-Romero I, Pérez-Padilla R, Aguilar-Faisal JL, Vázquez-Pérez JA. Serna-Muñoz R, et al. Vaccines (Basel). 2022 Dec 1;10(12):2063. doi: 10.3390/vaccines10122063. Vaccines (Basel). 2022. PMID: 36560474 Free PMC article.
Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study.
Avila-Rios S, Ormsby CE, Carlson JM, Valenzuela-Ponce H, Blanco-Heredia J, Garrido-Rodriguez D, Garcia-Morales C, Heckerman D, Brumme ZL, Mallal S, John M, Espinosa E, Reyes-Teran G. Avila-Rios S, et al. Retrovirology. 2009 Aug 10;6:72. doi: 10.1186/1742-4690-6-72. Retrovirology. 2009. PMID: 19664284 Free PMC article.
Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.
Matthews PC, Koyanagi M, Kløverpris HN, Harndahl M, Stryhn A, Akahoshi T, Gatanaga H, Oka S, Juarez Molina C, Valenzuela Ponce H, Avila Rios S, Cole D, Carlson J, Payne RP, Ogwu A, Bere A, Ndung'u T, Gounder K, Chen F, Riddell L, Luzzi G, Shapiro R, Brander C, Walker B, Sewell AK, Reyes Teran G, Heckerman D, Hunter E, Buus S, Takiguchi M, Goulder PJ. Matthews PC, et al. J Virol. 2012 Dec;86(23):12643-54. doi: 10.1128/JVI.01381-12. Epub 2012 Sep 12. J Virol. 2012. PMID: 22973023 Free PMC article.
Impact of HLA-B*35 subtype differences on HIV disease outcome in Mexico.
Juarez-Molina CI, Valenzuela-Ponce H, Avila-Rios S, Garrido-Rodriguez D, Garcia-Tellez T, Soto-Nava M, Garcia-Morales C, Goulder P, Reyes-Teran G. Juarez-Molina CI, et al. AIDS. 2014 Jul 17;28(11):1687-90. doi: 10.1097/QAD.0000000000000322. AIDS. 2014. PMID: 24853499
119 results